Synthesis, anti-inflammatory activity, and molecular docking studies of some novel Mannich bases of the 1,3,4-oxadiazole-2(3H)-thione scaffold
| dc.contributor.author | Ozyazici, Tugce | |
| dc.contributor.author | Gurdal, Enise E. | |
| dc.contributor.author | Orak, Duygu | |
| dc.contributor.author | Sipahi, Hande | |
| dc.contributor.author | Ercetin, Tuba | |
| dc.contributor.author | Gulcan, Hayrettin O. | |
| dc.contributor.author | Koksal, Meric | |
| dc.date.accessioned | 2026-02-06T18:29:11Z | |
| dc.date.issued | 2020 | |
| dc.department | Doğu Akdeniz Üniversitesi | |
| dc.description.abstract | A series of novel ibuprofen and salicylic acid-based 3,5-disubstituted-1,3,4-oxadiazole-2(3H)-thione derivatives was synthesized, and they were evaluated as potential anti-inflammatory agents. Following the structure identification studies employing IR, H-1 nuclear magnetic resonance (NMR), C-13 NMR, and elemental analysis, the title compounds were tested by cyclooxygenase (COX)-1 and COX-2 inhibition assays concomitant to lipopolysaccharide (LPS)-induced nitric oxide and prostaglandin production prevention experiments. The results indicated that the majority of the compounds displayed either a superior or comparable activity in preventing both LPS-induced NO production and COX-1 activity in comparison to the activities of the reference molecules. Furthermore, docking studies were also performed to reveal possible interactions with the COX enzymes. | |
| dc.identifier.doi | 10.1002/ardp.202000061 | |
| dc.identifier.issn | 0365-6233 | |
| dc.identifier.issn | 1521-4184 | |
| dc.identifier.issue | 7 | |
| dc.identifier.orcid | 0000-0003-4203-6135 | |
| dc.identifier.orcid | 0000-0001-6482-3143 | |
| dc.identifier.orcid | 0000-0003-1064-8639 | |
| dc.identifier.orcid | 0000-0002-9503-5841 | |
| dc.identifier.pmid | 32319141 | |
| dc.identifier.scopus | 2-s2.0-85083742145 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1002/ardp.202000061 | |
| dc.identifier.uri | https://hdl.handle.net/11129/11322 | |
| dc.identifier.volume | 353 | |
| dc.identifier.wos | WOS:000527293400001 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | PubMed | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Wiley-V C H Verlag Gmbh | |
| dc.relation.ispartof | Archiv Der Pharmazie | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260204 | |
| dc.subject | 1 | |
| dc.subject | 3 | |
| dc.subject | 4-oxadiazole | |
| dc.subject | anti-inflammatory activity | |
| dc.subject | COX-1 | |
| dc.subject | COX-2 | |
| dc.subject | LPS-induced NO production | |
| dc.subject | molecular docking study | |
| dc.subject | PGE(2) | |
| dc.title | Synthesis, anti-inflammatory activity, and molecular docking studies of some novel Mannich bases of the 1,3,4-oxadiazole-2(3H)-thione scaffold | |
| dc.type | Article |










